http://www.lyratherapeutics.com
Lyra Therapeutics, Inc. Company Intro
We are pioneering a new therapeutic approach to treat debilitating ear, nose and throat (ENT) diseases that impact the lives of millions of people.
Industry
Healthcare
Lyra Therapeutics, Inc. Headquaters
480 Arsenal Way
Watertown,02472
United States
Lyra Therapeutics, Inc. Share price
17 May 2023 13:30 GMT
$2.6000
-0.01 (-0.38 %)
Lyra Therapeutics, Inc. Market cap
$87.87 M
WMC RANKING
2023
Lyra Therapeutics, Inc. # 396
BiotechnologyLatest Lyra Therapeutics, Inc. News
03 Oct 2023
HC Wainwright & Co. Reiterates Lyra Therapeutics (LYRA ...
Lyra Therapeutics, Inc. is a clinical-stage therapeutics company focused on the development and commercialization of novel integrated drug and delivery...
03 Oct 2023
HC Wainwright & Co. Reiterates Lyra Therapeutics (LYRA ...
Lyra Therapeutics, Inc. is a clinical-stage therapeutics company focused on the development and commercialization of novel integrated drug and delivery...
02 Oct 2023
Analyst Expresses Optimistic Outlook on Lyra Therapeutics
On October 2, 2023, Matthew Caufield, an analyst from HC Wainwright & Co., expressed his optimistic outlook on Lyra Therapeutics (NASDAQ:LYRA). Caufield.
WMC Market Score
WMC Market to Revenue Score
Lyra Therapeutics, Inc. Market Financials
Revenue, Expenses, Profit
| Company | Currency | Revenue | Expense | Profit | Market Cap | WMC Sector Score |
| Lyra Therapeutics, Inc. | USD | $0 | $25,792 | $-25,727 | $879M | 396 |
| Regeneron Pharmaceuticals, Inc. | USD | $9,197,600 | $3,997,800 | $4,003,800 | $804,390B | 1 |
| Vertex Pharmaceuticals Incorporated | USD | $6,414,881 | $2,617,257 | $2,762,032 | $878,880B | 2 |
| Alexion Pharmaceuticals, Inc. | USD | $6,261,601 | $2,747,200 | $681,800 | $ | 3 |
| Incyte Corporation | USD | $2,702,913 | $2,048,306 | $478,480 | $144,340B | 4 |
Market Analytics
Company Search vs Top 4 Industry Competitors
Total Lyra Therapeutics, Inc. Social Followers vs Top 4 Industry Competitors
Lyra Therapeutics, Inc. Post vs Top 4 Industry Competitors
Lyra Therapeutics, Inc. Digital Footprint By Size vs Top 4 Industry Competitors
Lyra Therapeutics, Inc. Digital Footprint By Change Rate vs Top 4 Industry Competitors
Lyra Therapeutics, Inc. WMC Market Score Calculations
| Details | Revenue | Total Social Followers | Total Social Posts | Search Volume | Digital Footprint Size | Digital change (New Pages) | WMC Market Score |
| Lyra Therapeutics, Inc. | 0 | 0.92 | 0.00 | 0 | 0 | 0 | 0.40 |
| Regeneron Pharmaceuticals, Inc. | 100 | 25.50 | 16.15 | 28 | 0 | 0 | 29.94 |
| Vertex Pharmaceuticals Incorporated | 69.75 | 35.68 | 8.95 | 40 | 0 | 0 | 36.32 |
| Alexion Pharmaceuticals, Inc. | 68.08 | 100 | 100 | 32 | 0 | 0 | 100 |
| Incyte Corporation | 29.39 | 5.03 | 0.04 | 100 | 0 | 0 | 45.31 |
Book a demo
Book a free one-on-one demo with one of our team and see exactly how the WMC business intelligence platform can help you protect and grow revenue.
* required fields
You'll learn how to:
- 1. Automatically monitor your entire digital landscape including competitors
- 2. View all new industry activity in real time
- 3. Monitor your position in your industry
- 4. Enrich your reports and strategy
- 5. Empower your teams with knowledge
